Clinical trials
Left Ventricular Thrombus clinical trials
Below are recruiting left ventricular thrombus clinical trials, each written for real people, not researchers. We’re tracking 18 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05028777Recruiting
People with a heart clot who can join a hospital record study
This study looks at people age 18+ who were found to have a blood clot in the left side of the heart (left ventricular thrombus) on scans between 2013 and 2020. It will compare how different blood-thinner medicines were used and what outcomes occurred.
BernAges 18 years+ - NCT06963567Recruiting
Heart blood clot registry
This study keeps track of people who have or are at risk for a blood clot in the heart's main pumping chamber (left ventricle). It helps doctors learn more about how to care for these patients.
Cambridge, CambridgeshireAges 18 years+ - NCT06515730RecruitingPhase 4
Apixaban vs warfarin for left ventricle clot after heart attack
This trial tests whether a newer blood thinner, apixaban, works better than the standard warfarin for treating blood clots in the left ventricle after a heart attack. The goal is to see which medication is safer and more effective at preventing complications.
FalunAges 18 years+ - NCT07709780RecruitingPhase 3
Comparing two blood thinners for left ventricle blood clots
This trial compares the blood thinner apixaban to warfarin for treating blood clots in the main pumping chamber of the heart (left ventricle). The goal is to see which medicine is better at preventing strokes and other complications.
Tucson, ArizonaAges 18 years+ - NCT05794399RecruitingPhase 4
Blood thinner after heart attack with clot seen on MRI
This trial tests how to use a blood thinner in people after a recent heart attack who have a clot in the left heart chamber confirmed by heart MRI. It may help lower the risk of the clot causing serious complications, but it also requires careful bleeding-safety screening.
Kathmandu, BagmatiAges 18 years+ - NCT05892042Recruiting
Anticoagulant treatment for a heart clot after a heart attack
This trial studies whether a specific blood thinner can better treat a left-side heart clot found soon after a heart attack. It may help prevent the clot from getting worse or causing complications.
Changchun, JilinAges 18–80 - NCT06742567RecruitingPhase 3
Apixaban to prevent blood clots after a heart attack
This trial tests whether the blood thinner apixaban can prevent dangerous blood clots from forming in the heart's main pumping chamber after a specific type of heart attack. It is for patients who have severe weakness of the left ventricle and no clot already present.
Karachi, SindhAges 18–75 - NCT07053618Recruiting
Heart pump support for high-risk heart procedures
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
Beijing, Beijing MunicipalityAges 18–90 - NCT06013020RecruitingPhase 4
Blood thinner to prevent heart clots after a heart attack
This trial tests a blood thinner, rivaroxaban, to see if it can prevent blood clots from forming in the heart after a specific type of heart attack (STEMI) that affects the front part of the heart.
Zunyi, GuizhouAges 18–75 - NCT06127927Recruiting
Heart pump for severe heart failure
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
Fuzhou, FujianAges 18–75 - NCT07020702Recruiting
Predicting sudden cardiac death risk in heart muscle disease
This study looks at how the heart's electrical signals can predict sudden cardiac arrest in people with a weakened heart muscle. It may help doctors identify who is at highest risk.
Clermont-FerrandAges 18–80 - NCT07298122Recruiting
Heart imaging for hidden clots in ESUS stroke with left ventricular disease
This study uses advanced heart scans (MRI or CT) to look for blood clots in the heart of people who had a stroke with an unclear cause, specifically if they also have a mild heart condition affecting the left ventricle. The goal is to find hidden clots that might be causing strokes.
Milan, LombardyAges 18 years+ - NCT06425822Recruiting
Studying the left atrium in ventricular arrhythmia patients
This trial studies the upper left chamber of the heart (the left atrium) in people who have fast or irregular heartbeats from the lower chambers (ventricular arrhythmias). The goal is to see if there are specific patterns in the left atrium that might be linked to these arrhythmias, which could help tailor treatments in the future.
Jette, Brussels CapitalAges 18 years+ - NCT07380217Recruiting
Using heart pump support for complex high-risk procedures
This trial is testing whether using a special heart pump (PulseCath iVAC2L) during complex, high-risk angioplasty can help people with very weak hearts. It's for people who need a procedure for complicated coronary artery blockages.
AmsterdamAges 18 years+ - NCT05366452Recruiting
Early heart pump implant for shock after a heart attack
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
Marseille, Bouche DU RhoneAges 18–80 - NCT05411614Recruiting
Testing two heart procedures for atrial fibrillation in heart failure
This study compares two different ablation procedures (treatments that target heart rhythm triggers) for people with atrial fibrillation and reduced heart pumping. It aims to see which approach works best and is safest for improving your heart rhythm when you also have heart failure.
ChertseyAges 18 years+ - NCT06154044RecruitingPhase 2
Cell therapy for heart recovery with LVAD support
This trial tests whether injecting special cells (cell therapy) can help the heart recover in people with advanced heart failure who are getting a mechanical heart pump (LVAD). It may offer a new way to improve heart function and quality of life.
LjubljanaAges 18–65 - NCT06831825RecruitingPhase 1
Gene therapy for heart failure recovery trial
This trial tests a gene therapy injected into the heart to help it recover after a previous heart attack. It may be an option for people with stable heart failure who are not eligible for standard procedures like stents or bypass surgery.
Houston, TexasAges 18–79
Hear when a new Left Ventricular Thrombus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for left ventricular thrombus?
- Yes. Clin2 currently lists 18 recruiting left ventricular thrombus studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a left ventricular thrombus trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a left ventricular thrombus trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.